Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Mitral regurgitation Stories

2013-10-25 10:20:47

Scientists also found that gene disrupts heart valve development & growth Research on the DNA of a large multi-generational family has provided a genetic clue that enabled scientists to pinpoint a gene that plays a role in mitral valve prolapse (MVP), a common cardiac disease that is a leading cause of heart failure, according to a study presented today (Thursday, Oct. 24) at the American Society of Human Genetics 2013 meeting in Boston. The scientists who located the gene, named...

2013-10-25 08:25:42

Treatment with Minimally Invasive Device Can Improve Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk ABBOTT PARK, Ill., Oct. 25, 2013 /PRNewswire/ -- Abbott today announced that its first-in-class, catheter-based MitraClip(®) therapy has received U.S. Food and Drug Administration (FDA) approval and will launch immediately in the United States, providing physicians with a breakthrough treatment option for patients suffering...

2013-10-24 08:36:04

Valtech Cardio to present a clinical update on the Cardioband(TM) feasibility study at the TCT Symposium OR YEHUDA, Israel, October 24, 2013 /PRNewswire/ -- Valtech Cardio [http://www.valtechcardio.com ] Ltd, a medical device company that develops solutions for mitral valve repair and replacement, announced today that 11 patients have been treated with the company's transcatheter (transfemoral) Cardioband(TM) Annuloplasty System in three leading European medical centers....

2013-10-24 08:34:20

Neovasc's Tiara(TM) Program for the Transcatheter Treatment of Mitral Valve Disease Will Be Featured in Two Sessions VANCOUVER, Oct. 24, 2013 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that researchers will present data on the company's Tiara(TM) transcatheter mitral valve in preclinical development for the treatment of mitral valve disease at the upcoming 25(th) Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the...

2013-10-01 17:56:33

Mayo Clinic study examines costs following operating room and recovery improvement efforts The total hospital cost of mitral valve repair surgery — from the time a patient is admitted to the hospital until release — is similar, whether performed through small port incisions using robotic equipment or via the conventional open-chest method, a Mayo Clinic study of 370 patients found. Importantly, robotic surgeries were just as safe as conventional open procedures, but patients who...

2013-08-15 08:28:17

--Year-over-Year Revenues Increased 71% from Robust Growth in Contract Manufacturing and Consulting Services Revenues-- TSX Venture Exchange: NVC VANCOUVER, Aug. 15, 2013 /PRNewswire/ - Neovasc Inc. ("Neovasc") (TSXV: NVC), today announced financial results for the three and six months ended June 30, 2013. "We continued to deliver on our planned progress in all of Neovasc's programs during the second quarter," commented Alexei Marko, chief executive officer of Neovasc. ...

2013-08-14 12:22:08

In a study that included patients with mitral valve regurgitation due to a condition known as flail mitral valve leaflets, performance of early surgical correction compared with initial medical management was associated with greater long-term survival and lower risk of heart failure, according to a study in the August 14 issue of JAMA. "Degenerative mitral regurgitation [backflow of blood from the left ventricle to the left atrium due to mitral valve insufficiency] is common and can be...

2013-08-14 11:56:21

Mayo Clinic-led international study challenges long-held belief Patients with severe mitral valve regurgitation who are otherwise healthy should have mitral valve repair surgery sooner rather than later, even if they feel no symptoms, a Mayo Clinic-led study by U.S. and European researchers found. The results challenge the long-held belief that it is safer to "watch and wait" until a patient has symptoms, such as shortness of breath. This is the largest study to show that patients who...

2013-07-01 16:26:03

Scripps Clinic only trial site in San Diego to offer MitraClip device SAN DIEGO, July 1, 2013 /PRNewswire/ -- Virginia Anderer, a native of Chicago, never thought she would see her beloved city again due to her failing heart which prevented her from traveling. But the 84-year-old Southern California resident was recently able to return to the Windy City - with her doctor's blessing - thanks in part to a minimally invasive device that has the potential to fix her leaky heart valve....

2013-06-26 12:31:47

PALO ALTO, California and MUNICH, June 26, 2013 /PRNewswire/ -- Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised $8.5M in a Series A financing. The round was co-led by healthcare investment specialists Wellington Partners and Seventure Partners, along with seed investor High-Tech Gruenderfonds Management GmbH (HTGF). The proceeds will provide capital for further...